Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,802
Closed -$919K 512
2023
Q1
$919K Buy
+3,802
New +$933K 0.1% 316
2022
Q2
Sell
-1,803
Closed -$436K 592
2022
Q1
$436K Sell
1,803
-1,996
-53% -$459K 0.05% 498
2021
Q4
$855K Buy
+3,799
New +$802K 0.09% 323
2021
Q3
Sell
-2,304
Closed -$562K 517
2021
Q2
$562K Buy
+2,304
New +$567K 0.05% 417
2021
Q1
Sell
-20,013
Closed -$4.6M 527
2020
Q4
$4.6M Buy
+20,013
New +$4.61M 0.34% 63
2020
Q3
Sell
-1,583
Closed -$373K 568
2020
Q2
$373K Buy
+1,583
New +$361K 0.03% 331
2019
Q4
Sell
-60,690
Closed -$11.7M 373
2019
Q3
$11.7M Buy
+60,690
New +$11.6M 0.66% 27
2019
Q2
Sell
-29,850
Closed -$5.67M 225
2019
Q1
$5.67M Buy
29,850
+9,390
+46% +$1.79M 0.34% 85
2018
Q4
$3.98M Buy
+20,460
New +$3.99M 0.23% 109

Other funds holding AMGN

Duality Advisers's AMGN Position: Q2 2023 in Review

Duality Advisers sold out of Amgen (AMGN) in Q2 2023, closing a stake of 3,802 shares — an estimated $919K sold.

Duality Advisers first reported a position in AMGN in Q4 2018 and held it in 9 quarters. The position peaked at $11.7M in Q3 2019. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Duality Advisers reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Duality Advisers sold 3,802 Amgen shares in Q2 2023, an estimated $919K.
  • Duality Advisers first reported a position in Amgen in Q4 2018 and held it in 9 quarters.
  • Duality Advisers's Amgen position peaked at $11.7M in Q3 2019.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Duality Advisers's 13F filing for Q2 2023, filed 31 Jul 2023.